ConductScience.org, home

Paper39650663

Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer.

Guo X and 6 others. Front Immunol, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer. Papers, record 39650663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39650663

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.44, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo XXiao
2Xing JJiaying
3Cao YYuyan
4Yang WWenchuang
5Shi XXinlin
6Mu RRunhong
7Wang TTao

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
AnoikisMajor topic
Precision MedicineMajor topic
Machine LearningMajor topic
Humans
Female
Prognosis
Biomarkers, Tumor
Gene Expression Profiling
Transcriptome
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129092952TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.Cancer Res2017https://conductscience.org/library/papers/29092952PubMed
232124324EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data.Methods Mol Biol2020https://conductscience.org/library/papers/32124324PubMed
336282174Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.Elife2022https://conductscience.org/library/papers/36282174PubMed
431604482MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions.Genome Biol2019https://conductscience.org/library/papers/31604482PubMed
527765066Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.Genome Biol2016https://conductscience.org/library/papers/27765066PubMed
616199517Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16199517PubMed
730954475DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors.Cell Syst2019https://conductscience.org/library/papers/30954475PubMed
838504988Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making.Front Immunol2024https://conductscience.org/library/papers/38504988PubMed
929083409Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.Nat Genet2017https://conductscience.org/library/papers/29083409PubMed
1028836703Anoikis resistance and oncoviruses.J Cell Biochem2018https://conductscience.org/library/papers/28836703PubMed
1129262807A metastatic invasive mole arising from iatrogenic uterus perforation.BMC Cancer2017https://conductscience.org/library/papers/29262807PubMed
1236143281Application of Artificial Intelligence Techniques to Predict Risk of Recurrence of Breast Cancer: A Systematic Review.J Pers Med2022https://conductscience.org/library/papers/36143281PubMed
1326312921Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms.Lancet2015https://conductscience.org/library/papers/26312921PubMed
1435154121Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.Front Immunol2022https://conductscience.org/library/papers/35154121PubMed
1525098270Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.Nat Rev Cancer2014https://conductscience.org/library/papers/25098270PubMed
1614702756[Anoikis--a specific form of programmed cell death].Harefuah2003https://conductscience.org/library/papers/14702756PubMed
1720606088Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.J Clin Oncol2010https://conductscience.org/library/papers/20606088PubMed
1831819264NicheNet: modeling intercellular communication by linking ligands to target genes.Nat Methods2020https://conductscience.org/library/papers/31819264PubMed
1933771684Fibronectin regulates anoikis resistance via cell aggregate formation.Cancer Lett2021https://conductscience.org/library/papers/33771684PubMed
2031126321Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.Genome Med2019https://conductscience.org/library/papers/31126321PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41550348Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility.Front Digit Health2025https://conductscience.org/library/papers/41550348PubMed
40442841Revolutionizing breast cancer immunotherapy by integrating AI and nanotechnology approaches: review of current applications and future directions.Bioelectron Med2025https://conductscience.org/library/papers/40442841PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39650663

GET https://conductscience.org/api/papers/v1/39650663/references?page=2